It is not beyond the realm of possibility that somebody might want the Feb. 2016 2.40 warrants to expire worthless.
It's on YouTube. /wZj4JwqJBmM
Unless you are a short term investor in MNKD, you should look at the large short interest as very bullish. If you have faith in MNKD and have done your due diligence, sooner or later there is going to be that unexpected or expected piece of news that is going to send the shares flying. Then the squeeze begins. So please come in said the spider to the fly.
The Spider and the Fly
by Mary Howitt (1799-1888)
“Will you step into my parlor?” said the spider to the fly;
“’Tis the prettiest little parlor that ever you did spy.
The way into my parlor is up a winding stair,
And I have many pretty things to show when you are there.”
“O no, no,” said the little fly, “to ask me is in vain,
For who goes up your winding stair can ne’er come down again.”
“I’m sure you must be weary, dear, with soaring up so high;
Will you rest upon my little bed?” said the spider to the fly.
“There are pretty curtains drawn around, the sheets are fine and thin,
And if you like to rest awhile, I’ll snugly tuck you in.”
“O no, no,” said the little fly, “for I’ve often heard it said,
They never, never wake again, who sleep upon your bed.”
Said the cunning spider to the fly, “Dear friend, what shall I do,
To prove the warm affection I’ve always felt for you?
I have within my pantry good store of all that’s nice;
I’m sure you’re very welcome; will you please to take a slice?”
“O no, no,” said the little fly, “kind sir, that cannot be;
I’ve heard what’s in your pantry, and I do not wish to see.”
“Sweet creature!” said the spider, “You’re witty and you’re wise!
How handsome are your gauzy wings, how brilliant are your eyes!
I have a little looking-glass upon my parlor shelf,
If you’ll step in one moment, dear, you shall behold yourself.”
“I thank you, gentle sir,” she said, “for what you’re pleased to say,
And bidding you good-morning now, I’ll call another day.”
For the rest google The Spider and the Fly by Mary Howitt
Renewal rate looks good too, up 25% week to week.
BUZZ-Pricey borrowing costs don't stop MannKind short sellers
4:09 PM ET, 06/10/2015 - Reuters
** Shares of drugmaker MannKind slump 10.6 pct on Wednesday, cutting gain in 2015 to 14 pct ** Annualized cost of borrowing MannKind stock for shorting is at over 90 percent, according to SunGard's Astec Analytics ** Cost of borrowing MannKind stock was 85 percent two weeks ago, according to Sungard ** Stock a favorite of short sellers due partly to worries about weak sales of MannKind's much-hyped Afrezza inhalable insulin product ** Short interest at end of May grew to 32 pct of outstanding shares from 25 pct at end of April ** Company scores 94 out of 100 for likelihood of short squeeze, according to Thomson Reuters StarMine model. That's up from 92 last week
What 2 dozen countries? Are you saying they accept prescriptions now or awaiting AFREZZA approval? What is source of your information? Good info. if verified.
A 19 spage booklet entitled "Discover another approach to insulin"
see twitter /search?q=%23afrezza&src=typd